Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 13, 2013

Discovery Labs, Fibrogen, Pluristem, RXi, Tekmira, Vivus, Zysis

Preclinical
Tekmira posts Ebola, Marburg delay-to-treatment results . . . read more

Phase II
Discovery Labs cleared to begin IIa/b Aerosurf trial . . . read more

Fibrogen presents CKD-ESRD hemoglobin correction data . . . read more

Pluristem cleared by MFDS for IC trial . . . read more

RXi begins study in scar correction . . . read more

Filings
Vivus’ Qysmia receives two new patents . . . read more

Zysis gets LAO Aripiprazole patent . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters